DURECT Corporation (DRRX)
NASDAQ: DRRX
· Real-Time Price · USD
1.91
-0.02 (-1.04%)
At close: Sep 10, 2025, 3:59 PM
-1.04% (1D)
| Bid | 1.92 |
| Market Cap | 59.31M |
| Revenue (ttm) | 3.15M |
| Net Income (ttm) | -3.48M |
| EPS (ttm) | -0.43 |
| PE Ratio (ttm) | -4.441860465116279 |
| Forward PE | -2.73 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 1.94 |
| Volume | 2,140,904 |
| Avg. Volume (20D) | 1,193,359 |
| Open | 1.91 |
| Previous Close | 1.93 |
| Day's Range | 1.91 - 1.91 |
| 52-Week Range | 0.48 - 2.64 |
| Beta | 0.93 |
| Ex-Dividend Date | n/a |
About DRRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DRRX
Website n/a
DURECT Corporation is scheduled to release its earnings on
Nov 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+240.15%
DURECT shares are trading higher after announcing ...
Unlock content with
Pro Subscription
4 weeks ago · accessnewswire.com
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and DURECT Corporation (NASDAQ:DRRX) t...
